Plasma and Intracellular Pharmacokinetics of Tenofovir in Patients Switched from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide.

about

Plasma and Intracellular Pharmacokinetics of Tenofovir in Patients Switched from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide.

Item

http://www.wikidata.org/entity/Q48506430

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Plasma and Intracellular Pharm ...... rate to Tenofovir Alafenamide.

@en

Plasma and Intracellular Pharm ...... rate to Tenofovir Alafenamide.

@nl

type

Item

label

Plasma and Intracellular Pharm ...... rate to Tenofovir Alafenamide.

@en

Plasma and Intracellular Pharm ...... rate to Tenofovir Alafenamide.

@nl

prefLabel

Plasma and Intracellular Pharm ...... rate to Tenofovir Alafenamide.

@en

Plasma and Intracellular Pharm ...... rate to Tenofovir Alafenamide.

@nl

P1476

Plasma and intracellular pharm ...... arate to tenofovir alafenamide

@en

P2093

Anthony T Podany

http://www.w3.org/2001/XMLSchema#string

Courtney V Fletcher

http://www.w3.org/2001/XMLSchema#string

Jennifer O'Neill

http://www.w3.org/2001/XMLSchema#string

Joshua Havens

http://www.w3.org/2001/XMLSchema#string

Sara H Bares

http://www.w3.org/2001/XMLSchema#string

Sarah Lee

http://www.w3.org/2001/XMLSchema#string

Shetty Ravi Dyavar

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions.

Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.

Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.

A rapid spin through oil results in higher cell-associated concentrations of antiretrovirals compared with conventional cell washing.

Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

P304

761-765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001744

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

K K Scarsi

Susan Swindells

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29334548

http://www.w3.org/2001/XMLSchema#string

P932

5854526

http://www.w3.org/2001/XMLSchema#string